critical review report: fub-amb (mmb-fubinaca, amb-fubinaca)
Critical Review Report: FUB-AMB (MMB-FUBINACA, AMB-FUBINACA)
Critical Review Report: FUB-AMB (MMB-FUBINACA, AMB-FUBINACA) Expert Committee on Drug Dependence Forty-first Meeting Geneva, 12-16 November 2018 This report contains the views of an international group of experts, and does not necessarily represent the decisions or the stated policy of the World Health Organization
An outbreak of deaths associated with AMB-FUBINACA
AMB-FUBINACA is a synthetic cannabinoid that has been associated with periodic outbreaks of acute poisonings, but few fatalities. In late May, June and July 2017 Auckland, New Zealand, experienced an outbreak of deaths associated with AMB-FUBINACA that continued at a rate of about 2–3 per month through February 2019.
AMB-FUBINACA & Other Synthetic Cannabinoids – Backgrounder
The drug AMB-FUBINACA (methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate), is a synthetic cannabinoid, commonly known as “K2”, “spice”, “kronic” or “fake weed”. It was first synthesized by Pfizer in 2009, along with numerous other related compounds. It is also known as FUB-AMB and MMB-FUBINACA.
“Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB
The synthetic cannabinoid methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (AMB-FUBINACA, also known as MMB-FUBINACA or FUB-AMB) was identified in AK-47 24 Karat Gold at a
The phenomenon of para-Fluorophenylpiperazine (pFPP)
World Health OrganizationCritical Review Report: FUB-AMB (MMB-FUBINACA, AMB-FUBINACA) Expert Committee on Drug Dependence, Forty-first meeting, Geneva (2018) 12–16 November
(PDF) "zombie" outbreak caused by the synthetic cannabinoid
3-methylbuta noate (AMB-FUBINACA, also know n as MMB-FUBINACA or FUB-AMB) was identif ied i n AK-47 2 4 Karat Gold at a mean (±SD) concentration of 16.0±3.9 mg per gram.
An outbreak of deaths associated with AMB-FUBINACA
Background. AMB-FUBINACA is a synthetic cannabinoid that has been associated with periodic outbreaks of acute poisonings, but few fatalities. In late May, June and July 2017 Auckland, New Zealand, experienced an outbreak of deaths associated with AMB-FUBINACA that continued at a rate of about 2–3 per month through February 2019.
Comprehensive investigation on synthetic cannabinoids
RESULTS The synthetic cannabinoid methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (AMB-FUBINACA, also known as MMB-FUBINACA or FUB-AMB) was identified in AK-47 24 Karat
The Contributor | FDA Requests Public Commentary on Proposed
FUB-AMB (MMB-FUBINACA, AMB-FUBINACA) ADB-CHMINACA. CUMYL-4CN-BINACA. FENTANYLS. Cyclopropyl Fentanyl. Methoxyacetyl Fentanyl. Ortho-Fluorofentanyl. Para- Fluoro Butyrfentanyl. Para-Methoxybutyrfentanyl (METH)CATHINONE. N-Ethylnorpentylone. MEDICINES. Tramadol. Pregabalin
Alston & Bird Healthcare Week in Review - March 2020 #4
The DEA places methyl 2-(1-(4- fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (other names: FUBAMB, MMB-FUBINACA, AMB-FUBINACA), including its salts, isomers, and salts of isomers
scheduling recommendations by the World Health I
FUB-AMB (MMB-FUBINACA, AMB-FUBINACA), CUMYL-4CN-BINACA, ADB-CHMINACA (MAB-CHMINACA) and N-ethylnorpentylone (ephylone) in Schedule II of that Convention. 2. In accordance with the provisions of article 3, paragraph 2, of the 1961 Convention, and article 2, paragraph 2, of the 1971 Convention, the Secretary-General
Brain Sciences | Free Full-Text | Potential Mechanisms
The chief psychoactive constituent of many bioactive phytocannabinoids (Δ9-tetrahydrocannabinol, Δ9-THC) found in hemp, cannabis or marijuana plants are scientifically denoted by the Latin term, Cannabis sativa, acts on cell surface receptors. These receptors are ubiquitously expressed. To date, two cannabinoid receptors have been cloned and characterized. Cannabinoid receptor type